SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-19-000117
Filing Date
2019-12-17
Accepted
2019-12-17 20:00:32
Documents
1
Period of Report
2019-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157663081447676.html 4  
1 FORM 4 wf-form4_157663081447676.xml 4 3591
  Complete submission text file 0001479290-19-000117.txt   4893
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address
Sjuts Dustin S (Reporting) CIK: 0001796224 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 191291084